Alerts
Alzheimer’s Blood Tests Are Changing Decisions, Not Just Diagnoses
A randomised trial found that earlier disclosure of p-tau217 and neurofilament light results dramatically increased diagnostic certainty and changed management without increasing distress. Alzheimer’s blood biomarkers have crossed from accuracy into clinical utility.
AMR Has An Equity Problem
Brain Tumour Surgery Is Getting Smaller. Access Cannot Stay Elite.
Canada Moves. Alzheimer’s Patients Still Wait.
Prostate Cancer Treatment Is Creating a Metabolic Bill
Hodgkin Lymphoma Survivors Are Still Paying for Cure
Sanfilippo’s Approval Path Is Being Built Before Approval
Pertussis Rose. The Definition Amplified It.
Parkinson’s Gets a Cleaner Dopamine Bet
Europe Made Genomics Mandatory.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.